NSPR

$0.66+22.06%visit website

InspireMD, Inc.

Market Cap

$31M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.94

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

2.8

TTM to Jun 2026 · revenue

Flagged input, hover for details

P/B

1.0

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	2,523	3,149	3,398	1,771	10,841
Cost of revenue	1,659	1,969	2,711	2,545	8,884
Gross profit	864	1,180	687	(774)	1,957
Research & development	3,635	3,475	4,763	4,295	16,168
Total operating expenses	13,915	13,264	14,665	13,671	55,515
Operating income	(13,051)	(12,084)	(13,978)	(14,445)	(53,558)
Net income	(12,708)	(11,761)	(13,689)	(14,324)	(52,482)
EPS (basic) ($)	(0.17)		(0.16)	(0.17)	(0.61)
EPS (diluted) ($)	(0.17)		(0.16)	(0.17)	(0.61)
Weighted avg. shares (basic)	73,467		83,802	84,660
Weighted avg. shares (diluted)	73,467		83,802	84,660

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

15 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Sep 21, 2026 accepted 9:12 AM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Aug 17, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Jul 29, 2026 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Jul 23, 2026 accepted 5:00 PM ET	3.01Delisting notice	Document SEC ↗
Jul 2, 2026 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Jun 11, 2026 accepted 8:05 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jun 3, 2026 accepted 4:05 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
May 22, 2026 accepted 4:05 PM ET	5.02Officer / director change	Document SEC ↗
May 4, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
May 1, 2026 accepted 4:07 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

60%

W/W +14.4pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-27	2026-05-29	Stuka Paul	Director	Purchase	20.0K	$0.88	$18K	667.9K	View
2026-05-19	2026-05-21	Gleason Shane Thomas	Chief Commercial Officer	Sale	22.8K	$1.01	$23K	1.05M	View
2026-02-02	2026-05-21	Gleason Shane Thomas	Chief Commercial Officer	Sale	2,941	$1.59	$5K	1.08M	View
2025-05-30	2026-05-21	Gleason Shane Thomas	Chief Commercial Officer	Sale	7,186	$2.51	$18K	1.08M	View
2025-05-29	2026-05-21	Gleason Shane Thomas	Chief Commercial Officer	Sale	3,760	$2.51	$9K	1.09M	View

1–5 of 30

1 / 6

Recent News

Missing the 13% Rally in Penny Stock InspireMD (NASDAQ:NSPR) After Its Recall Drop and Ahead of November 12 Earnings?

Kalkine · 2026-11-03

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 2026-11-02

InspireMD to Announce Third Quarter 2026 Financial Results

Yahoo · 2026-10-29

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-16

An anticipated FDA approval could open up $11 million for InspireMD's stroke-prevention device.

Stock Titan · 2026-09-21

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance · 2026-09-04

InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-03

InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know

Yahoo Finance · 2026-08-20

InspireMD Inc (NSPR) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges While ...

Yahoo Finance · 2026-08-17

InspireMD, Inc. Q2 2026 Earnings Call Summary

Yahoo Finance · 2026-08-17

InspireMD Reports Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-17

Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares

Investing.com · 2026-08-17

InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates

Yahoo Finance · 2026-08-14

INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More

Quiver Quantitative · 2026-08-14

InspireMD to Announce Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-10

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-05-27	Stuka Paul	P	20,000	$17,500
2026-05-19	Gleason Shane Thomas	S	22,778	$23,005.78
2026-02-02	Gleason Shane Thomas	S	2,941	$4,676.19
2025-05-30	Gleason Shane Thomas	S	7,186	$18,036.86
2025-05-29	Gleason Shane Thomas	S	3,760	$9,437.6

NSPR

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

InspireMD, Inc. (NSPR)

Reporting Insiders

Factor Profile

Corporate Events (8-K)